Simple blood draw may spot brain damage in mild head injuries
NCT ID NCT02639923
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether tiny molecules in the blood, called microRNAs, can help tell if someone with a mild head injury has actual brain damage visible on a CT scan. Researchers took blood samples from 155 people with mild traumatic brain injury and compared those with and without brain lesions, plus a healthy control group. The goal was to see if these blood markers could replace or reduce the need for CT scans, but the results showed no significant differences between the groups.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a simple blood test to quickly identify which mild head injury patients have hidden brain damage.
What could go wrong
This is a small pilot study, not a treatment trial. The biomarkers tested did not show significant differences between groups, so the approach may not be useful in practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN INJURIES, TRAUMATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical University of Vienna
Vienna, State of Vienna, A-1090, Austria